Fujirebio Oct 29, 2021 In Brief This Week: PerkinElmer, Fujirebio Europe, Exagen, Genetic Technologies, and More Mar 4, 2021 Norwegian Startup Pre Diagnostics Developing Monocyte Test for Presymptomatic Alzheimer's Disease Premium Jan 7, 2021 Fujirebio Seeks to Expand Alzheimer's Test Portfolio With FDA Submission for β-Amyloid Ratio Assay Premium Dec 8, 2020 Fujirebio Europe, Ohmx.bio Nab $873K Grant to Develop Clinical Third-Generation Sequencing Platform Dec 2, 2020 Fujirebio Diagnostics Applies for FDA 510(k) Clearance for Alzheimer's Disease Test Nov 9, 2020 Centogene to Offer Fujirebio SARS-CoV-2 Antigen Test at German Airports Jun 8, 2020 Siemens Healthineers, Hologic, DiaSorin, BioMérieux, Others Get FDA Clearances in May May 22, 2020 Local Coverage Determinations Roundup: Aspira Labs, Fujirebio Diagnostics Sep 10, 2019 BioMérieux, Siemens Healthineers, Roche Diagnostics, Others Get FDA Clearances in August Feb 15, 2019 In Brief This Week: BioDirection, Quest Diagnostics, OncoCyte, and More Dec 13, 2018 InterVenn Aims to Push Glycoproteomics Into the Clinic Premium Jun 12, 2018 FDA Clears Fujirebio Diagnostics G BRAHMS Procalcitonin Assay Apr 26, 2018 Fujirebio, Janssen Collaborate on Test for Alzheimer's Drug Jan 17, 2018 Tests, Systems From Beckman Coulter, BioMérieux, Siemens Healthineers Receive FDA Clearance in December Sep 5, 2017 Morphotek, Fujirebio to Develop CA125 II Assay as CDx Breaking News KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure 360Dx Top 30 Grows 8 Percent, Continues Upward Climb HemoSonics Nabs FDA 510(k) for Cartridge-Based Blood Hemostasis Assay Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay
